Omega Fund Management’s Palvella Therapeutics PVLA Stock Holding History

Omega Fund Management’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,822	Closed	-$580K	–	24
2021 Q1	$580K	Sell	2,822 -6,562	-70%	-$1.43M	0.05%	24
2020 Q4	$1.88M	Hold	9,384	–	–	0.28%	19
2020 Q3	$1.55M	Hold	9,384	–	–	0.42%	16
2020 Q2	$2.33M	Hold	9,384	–	–	0.64%	15
2020 Q1	$1.71M	Hold	9,384	–	–	0.71%	16
2019 Q4	$2.72M	Hold	9,384	–	–	0.87%	14
2019 Q3	$2.56M	Sell	9,384 -47	-0.5%	-$18.2K	0.79%	13
2019 Q2	$3.55M	Sell	9,431 -297	-3%	-$88.6K	0.9%	11
2019 Q1	$2.61M	Hold	9,728	–	–	0.84%	11
2018 Q4	$2.07M	Hold	9,728	–	–	1.53%	10
2018 Q3	$4.36M	Hold	9,728	–	–	2.06%	10
2018 Q2	$3.95M	Hold	9,728	–	–	2.91%	11
2018 Q1	$5.31M	Sell	9,728 -1,573	-14%	-$974K	5.22%	7
2017 Q4	$6.83M	Sell	11,301 -3,750	-25%	-$1.74M	4.94%	6
2017 Q3	$6.93M	Sell	15,051 -2,040	-12%	-$871K	3.92%	6
2017 Q2	$6.92M	Sell	17,091 -4,126	-19%	-$1.21M	4.32%	6
2017 Q1	$4.41M	Hold	21,217	–	–	2.87%	8
2016 Q4	$2.38M	Sell	21,217 -1,895	-8%	-$235K	1.93%	8
2016 Q3	$3.38M	Sell	23,112 -5,173	-18%	-$687K	2.58%	7
2016 Q2	$3.64M	Sell	28,285 -2,764	-9%	-$424K	2.7%	7
2016 Q1	$4.72M	Hold	31,049	–	–	3.27%	7
2015 Q4	$5.69M	Hold	31,049	–	–	3.17%	6
2015 Q3	$4.55M	Buy	+31,049	New	+$6.93M	2.56%	7

Other funds holding PVLA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Omega Fund Management's PVLA Position: Q2 2021 in Review

Omega Fund Management sold out of Palvella Therapeutics (PVLA) in Q2 2021, closing a stake of 2,822 shares — an estimated $580K sold.

Omega Fund Management first reported a position in PVLA in Q3 2015 and held it in 23 quarters. The position peaked at $6.93M in Q3 2017. 73 funds tracked by Wall St. Rank hold PVLA as of Q2 2021.

Omega Fund Management reported no remaining Palvella Therapeutics position as of Q2 2021 after selling out during the quarter.
Omega Fund Management sold 2,822 Palvella Therapeutics shares in Q2 2021, an estimated $580K.
Omega Fund Management first reported a position in Palvella Therapeutics in Q3 2015 and held it in 23 quarters.
Omega Fund Management's Palvella Therapeutics position peaked at $6.93M in Q3 2017.
73 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2021.

Based on Omega Fund Management's 13F filing for Q2 2021, filed 16 Aug 2021.